HEADER TRANSFERASE 09-MAR-06 2CGU TITLE IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY TITLE 2 RECEPTOR-BASED VIRTUAL SCREENING COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL KINASE DOMAIN, RESIDUES 1-289; COMPND 5 SYNONYM: CHK1 KINASE; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1/CHK1 1-289 C8H KEYWDS TRANSFERASE, DOCKING, DRUG DESIGN, ONCOLOGY, VIRTUAL KEYWDS 2 SCREENING, ATP- BINDING, CELL CYCLE, DNA DAMAGE, DNA KEYWDS 3 REPAIR, KINASE, NUCLEAR PROTEIN, NUCLEOTIDE-BINDING, KEYWDS 4 PHOSPHORYLATION, POLYMORPHISM, SERINE/THREONINE-PROTEIN KEYWDS 5 KINASE, UBL CONJUGATION EXPDTA X-RAY DIFFRACTION AUTHOR N.FOLOPPE,L.M.FISHER,R.HOWES,A.POTTER,A.G.S.ROBERTSON, AUTHOR 2 A.E.SURGENOR REVDAT 3 24-FEB-09 2CGU 1 VERSN REVDAT 2 31-MAY-06 2CGU 1 JRNL REVDAT 1 05-APR-06 2CGU 0 JRNL AUTH N.FOLOPPE,L.M.FISHER,R.HOWES,A.POTTER, JRNL AUTH 2 A.G.S.ROBERTSON,A.E.SURGENOR JRNL TITL IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 JRNL TITL 2 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING. JRNL REF BIOORG.MED.CHEM. V. 14 4792 2006 JRNL REFN ISSN 0968-0896 JRNL PMID 16574416 JRNL DOI 10.1016/J.BMC.2006.03.021 REMARK 2 REMARK 2 RESOLUTION. 2.5 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.09 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 74.8 REMARK 3 NUMBER OF REFLECTIONS : 7709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 408 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 180 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 19 REMARK 3 BIN FREE R VALUE : 0.3040 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2130 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.71000 REMARK 3 B22 (A**2) : 0.44000 REMARK 3 B33 (A**2) : 2.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.35000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.416 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.267 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.875 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2207 ; 0.021 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2990 ; 2.059 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 261 ; 7.414 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 391 ;20.781 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;14.584 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 319 ; 0.145 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1684 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1008 ; 0.250 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 142 ; 0.203 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.314 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.737 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1313 ; 1.084 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2124 ; 2.063 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 894 ; 2.749 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 866 ; 4.515 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2CGU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAR-06. REMARK 100 THE PDBE ID CODE IS EBI-28097. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97920 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11961 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 70.5 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 22.1 REMARK 200 DATA REDUNDANCY IN SHELL : 0.90 REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1IA8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.9 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.9 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.89350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REQUIRED FOR CHECKPOINT MEDIATED CELL CYCLE ARREST IN REMARK 400 RESPONSE TO DNA DAMAGE OR THE PRESENCE OF UNREPLICATED DNA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 VAL A 3 REMARK 465 PRO A 4 REMARK 465 PHE A 5 REMARK 465 ALA A 45 REMARK 465 VAL A 46 REMARK 465 ASP A 47 REMARK 465 GLY A 272 REMARK 465 ALA A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 PRO A 276 REMARK 465 ARG A 277 REMARK 465 VAL A 278 REMARK 465 THR A 279 REMARK 465 SER A 280 REMARK 465 GLY A 281 REMARK 465 GLY A 282 REMARK 465 VAL A 283 REMARK 465 SER A 284 REMARK 465 GLU A 285 REMARK 465 SER A 286 REMARK 465 PRO A 287 REMARK 465 SER A 288 REMARK 465 GLY A 289 REMARK 465 HIS A 290 REMARK 465 HIS A 291 REMARK 465 HIS A 292 REMARK 465 HIS A 293 REMARK 465 HIS A 294 REMARK 465 HIS A 295 REMARK 465 HIS A 296 REMARK 465 HIS A 297 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 ARG A 44 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 51 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 169 - O HOH A 2096 2.05 REMARK 500 O ILE A 234 - O HOH A 2131 2.19 REMARK 500 O HOH A 2017 - O HOH A 2053 1.66 REMARK 500 O HOH A 2027 - O HOH A 2078 2.06 REMARK 500 O HOH A 2050 - O HOH A 2149 2.19 REMARK 500 O HOH A 2092 - O HOH A 2095 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 10 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 41 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP A 130 CB - CG - OD2 ANGL. DEV. = 7.3 DEGREES REMARK 500 LEU A 178 CA - CB - CG ANGL. DEV. = 21.4 DEGREES REMARK 500 ASP A 235 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 262 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 7 78.68 168.03 REMARK 500 ASP A 8 -35.55 60.56 REMARK 500 GLU A 32 2.00 81.70 REMARK 500 ASP A 99 -9.89 71.97 REMARK 500 ARG A 129 -2.68 79.85 REMARK 500 ASP A 130 45.22 -150.60 REMARK 500 ASP A 148 90.01 64.48 REMARK 500 GLN A 210 146.28 -170.19 REMARK 500 ASP A 235 138.54 106.14 REMARK 500 LEU A 269 -45.90 -137.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 CYS A 168 20.6 L L OUTSIDE RANGE REMARK 500 ILE A 234 24.5 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3A3 A1272 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IA8 RELATED DB: PDB REMARK 900 THE 1.7 A CRYSTAL STRUCTURE OF HUMAN REMARK 900 CELL CYCLE CHECKPOINTKINASE CHK1 REMARK 900 RELATED ID: 1NVQ RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF CHECKPOINT KINASE REMARK 900 CHK1/UCN-01 REMARK 900 RELATED ID: 1NVR RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF CHECKPOINT KINASECHK1 REMARK 900 /STAUROSPORINE REMARK 900 RELATED ID: 1NVS RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF CHECKPOINT KINASE REMARK 900 CHK1/SB218078 REMARK 900 RELATED ID: 2BR1 RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRB RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRG RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRH RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRM RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRN RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2BRO RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF NOVEL CHK1 REMARK 900 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND REMARK 900 PROTEIN-LIGAND AFFINITY REMARK 900 RELATED ID: 2C3J RELATED DB: PDB REMARK 900 IDENTIFICATION OF A BURIED POCKET FOR POTENT REMARK 900 AND SELECTIVE INHIBITION OF CHK1: PREDICTION REMARK 900 AND VERIFICATION REMARK 900 RELATED ID: 2C3K RELATED DB: PDB REMARK 900 IDENTIFICATION OF A BURIED POCKET FOR POTENT REMARK 900 AND SELECTIVE INHIBITION OF CHK1: PREDICTION REMARK 900 AND VERIFICATION REMARK 900 RELATED ID: 2C3L RELATED DB: PDB REMARK 900 IDENTIFICATION OF A BURIED POCKET FOR POTENT REMARK 900 AND SELECTIVE INHIBITION OF CHK1: PREDICTION REMARK 900 AND VERIFICATION REMARK 900 RELATED ID: 2CGV RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 REMARK 900 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING REMARK 900 RELATED ID: 2CGW RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 REMARK 900 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING REMARK 900 RELATED ID: 2CGX RELATED DB: PDB REMARK 900 IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 REMARK 900 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING DBREF 2CGU A 1 289 UNP O14757 CHK1_HUMAN 1 289 DBREF 2CGU A 290 297 PDB 2CGU 2CGU 290 297 SEQRES 1 A 297 MET ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN SEQRES 2 A 297 THR LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA SEQRES 3 A 297 VAL ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE SEQRES 4 A 297 VAL ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE SEQRES 5 A 297 LYS LYS GLU ILE CYS ILE ASN LYS MET LEU ASN HIS GLU SEQRES 6 A 297 ASN VAL VAL LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN SEQRES 7 A 297 ILE GLN TYR LEU PHE LEU GLU TYR CYS SER GLY GLY GLU SEQRES 8 A 297 LEU PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU SEQRES 9 A 297 PRO ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY SEQRES 10 A 297 VAL VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP SEQRES 11 A 297 ILE LYS PRO GLU ASN LEU LEU LEU ASP GLU ARG ASP ASN SEQRES 12 A 297 LEU LYS ILE SER ASP PHE GLY LEU ALA THR VAL PHE ARG SEQRES 13 A 297 TYR ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY SEQRES 14 A 297 THR LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG SEQRES 15 A 297 GLU PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY SEQRES 16 A 297 ILE VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP SEQRES 17 A 297 ASP GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP SEQRES 18 A 297 LYS GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE SEQRES 19 A 297 ASP SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL SEQRES 20 A 297 GLU ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS SEQRES 21 A 297 LYS ASP ARG TRP TYR ASN LYS PRO LEU LYS LYS GLY ALA SEQRES 22 A 297 LYS ARG PRO ARG VAL THR SER GLY GLY VAL SER GLU SER SEQRES 23 A 297 PRO SER GLY HIS HIS HIS HIS HIS HIS HIS HIS HET 3A3 A1272 25 HETNAM 3A3 2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL] HETNAM 2 3A3 BIS(OXY)}DIACETIC ACID FORMUL 2 3A3 C17 H13 N O7 FORMUL 3 HOH *156(H2 O1) HELIX 1 1 GLU A 50 LEU A 62 1 13 HELIX 2 2 PHE A 93 ILE A 96 5 4 HELIX 3 3 PRO A 103 ILE A 124 1 22 HELIX 4 4 LYS A 132 GLU A 134 5 3 HELIX 5 5 ASP A 148 ALA A 152 5 5 HELIX 6 6 THR A 170 VAL A 174 5 5 HELIX 7 7 ALA A 175 ARG A 181 1 7 HELIX 8 8 HIS A 185 GLY A 204 1 20 HELIX 9 9 CYS A 215 GLU A 223 1 9 HELIX 10 10 PRO A 230 ILE A 234 5 5 HELIX 11 11 ASP A 235 LEU A 246 1 12 HELIX 12 12 THR A 255 LYS A 260 1 6 HELIX 13 13 ARG A 263 LYS A 267 5 5 SHEET 1 AA 5 ASP A 10 THR A 14 0 SHEET 2 AA 5 GLY A 21 VAL A 27 -1 O LEU A 25 N VAL A 12 SHEET 3 AA 5 ALA A 34 ASP A 41 -1 O VAL A 35 N ALA A 26 SHEET 4 AA 5 ILE A 79 LEU A 84 -1 O GLN A 80 N VAL A 40 SHEET 5 AA 5 PHE A 70 ARG A 74 -1 N TYR A 71 O PHE A 83 SHEET 1 AB 3 GLY A 90 GLU A 91 0 SHEET 2 AB 3 LEU A 136 LEU A 138 -1 N LEU A 138 O GLY A 90 SHEET 3 AB 3 LEU A 144 ILE A 146 -1 O LYS A 145 N LEU A 137 SHEET 1 AC 2 ILE A 126 THR A 127 0 SHEET 2 AC 2 THR A 153 VAL A 154 -1 O THR A 153 N THR A 127 SHEET 1 AD 2 ARG A 156 TYR A 157 0 SHEET 2 AD 2 ARG A 160 GLU A 161 -1 O ARG A 160 N TYR A 157 CISPEP 1 ASN A 229 PRO A 230 0 6.37 SITE 1 AC1 10 LEU A 15 VAL A 23 ALA A 36 LYS A 38 SITE 2 AC1 10 GLU A 85 TYR A 86 CYS A 87 SER A 88 SITE 3 AC1 10 LEU A 137 ASP A 148 CRYST1 44.993 65.787 54.625 90.00 102.28 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022226 0.000000 0.004838 0.00000 SCALE2 0.000000 0.015201 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018735 0.00000 MASTER 436 0 1 13 12 0 3 6 0 0 0 23 END